Skip to main content
PMC home page
British Heart Journal logoLink to British Heart Journal
. 1973 Jul;35(7):734–737. doi: 10.1136/hrt.35.7.734

Action of verapamil on sinus node, atrioventricular, and intraventricular conduction.

M H Husaini, J Kvasnicka, L Ryèn, S Holmberg
PMCID: PMC458691  PMID: 4718824

Full text

PDF
735

Images in this article

735Image
on p.735
735Image
on p.735
735Image
on p.735
736Image
on p.736

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bender F. Isoptin zur Behandlung der tachykarden Form des Vorhofflatterns. Med Klin. 1967 Apr 21;62(16):634–636. [PubMed] [Google Scholar]
  2. Bender F., Zimmerhof K. Wenckebachsche Periode als Zeichen der Uberdosierung eines Mittels mit sympathikolytischer Herzwirkung. Med Welt. 1967 Jul 1;26:1585–1587. [PubMed] [Google Scholar]
  3. Finegan R. E., Marlon A. M., Harrison D. C. Circulatory effects of practolol. Am J Cardiol. 1972 Mar;29(3):315–322. doi: 10.1016/0002-9149(72)90525-5. [DOI] [PubMed] [Google Scholar]
  4. Garvey H. L. The mechanism of action of verapamil on the sinus and AV nodes. Eur J Pharmacol. 1969 Nov;8(2):159–166. doi: 10.1016/0014-2999(69)90071-5. [DOI] [PubMed] [Google Scholar]
  5. Goldreyer B. N., Bigger J. T., Jr Spontaneous and induced reentrant tachycardia. Ann Intern Med. 1969 Jan;70(1):87–98. doi: 10.7326/0003-4819-70-1-87. [DOI] [PubMed] [Google Scholar]
  6. Goldreyer B. N., Damato A. N. The essential role of atrioventricular conduction delay in the initiation of paroxysmal supraventricular tachycardia. Circulation. 1971 May;43(5):679–687. doi: 10.1161/01.cir.43.5.679. [DOI] [PubMed] [Google Scholar]
  7. MELVILLE K. I., SHISTER H. E., HUQ S. IPROVERATRIL: EXPERIMENTAL DATA ON CORONARY DILATATION AND ANTIARRHYTHMIC ACTION. Can Med Assoc J. 1964 Mar 28;90:761–770. [PMC free article] [PubMed] [Google Scholar]
  8. Neumann M., Luisada A. A. Double blind evaluation of orally administered iproveratril in patients with angina pectoris. Am J Med Sci. 1966 May;251(5):552–556. doi: 10.1097/00000441-196605000-00008. [DOI] [PubMed] [Google Scholar]
  9. Neuss H., Schlepper M. Der Einfluss von Verapamil auf die atrio-ventrikuläre Uberleitung. Lokalisation des Wirkungsortes mit His-Bündel Elektrogrammen. Verh Dtsch Ges Kreislaufforsch. 1971;37:433–438. [PubMed] [Google Scholar]
  10. Sandler G., Clayton G. A., Thornicroft S. G. Clinical evaluation of verapamil in angina pectoris. Br Med J. 1968 Jul 27;3(5612):224–227. doi: 10.1136/bmj.3.5612.224. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Schamroth L. Immediate effects of intravenous verapamil on atrial fibrillation. Cardiovasc Res. 1971 Oct;5(4):419–424. doi: 10.1093/cvr/5.4.419. [DOI] [PubMed] [Google Scholar]
  12. Schamroth L., Krikler D. M., Garrett C. Immediate effects of intravenous verapamil in cardiac arrhythmias. Br Med J. 1972 Mar 11;1(5801):660–662. doi: 10.1136/bmj.1.5801.660. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Scherlag B. J., Lau S. H., Helfant R. H., Berkowitz W. D., Stein E., Damato A. N. Catheter technique for recording His bundle activity in man. Circulation. 1969 Jan;39(1):13–18. doi: 10.1161/01.cir.39.1.13. [DOI] [PubMed] [Google Scholar]

Articles from British Heart Journal are provided here courtesy of BMJ Publishing Group

RESOURCES